FDA takes action against Abbvie for misleading Ubrelvy ad with Serena Williams
The Food and Drug Administration recently intervened regarding a migraine medication ad featuring tennis superstar Serena Williams.
FDA slams AbbVie for misleading claims in Serena Williams ad for migraine drug Ubrelvy
The FDA has faulted AbbVie’s promotion of the migraine drug Ubrelvy, calling the company out for an ad featuring Serena Williams that went out of bounds with claims about how quickly the product relieves symptoms.
'Aint She Rich Enuf?': Serena Williams Under Fire as the FDA Steps In Following 'Misleading' Commercial for Migraine Medicine Maker
A migraine medicine once-endorsed by Serena Williams has come under fire amid claims advertisements oversold it’s usefulness. Last month, on Aug. 29, the Food and […]
AbbVie faulted for misleading ad featuring Serena Williams
In the ad for oral CGRP inhibitor Ubrelvy (ubrogepant), Williams is depicted as suffering from a migraine while in a talk show dressing room, which resolves by the time she walks onto the set and allows her to carry out the interview laughing and pain-free.
FDA scolds AbbVie over ‘misleading’ TV ad for a migraine pill featuring Serena Williams
The FDA has scolded AbbVie for making false and misleading claims about a TV ad about a migraine pill that features Serena Williams.
FDA calls out AbbVie over ‘misleading’ commercial featuring Serena Williams
The U.S. Food and Drug Administration is taking North Chicago-based drugmaker AbbVie to task, warning in a recent letter that a migraine medication commercial featuring Serena Williams is “misleading.
Drug ad featuring Serena Williams is misleading, says FDA
The FDA (Food and Drug Administration) recently sent a letter expressing its dissatisfaction with a TV commercial featuring tennis player Serena Williams, stating that it contains several claims that are misleading to the public.
JD Supra1d
Ubrelvy Untitled Letter – A Double Fault for AbbVie? Or Makeup Misread for FDA?
The next frame shows the Ubrelvy logo in the backstage hallway along with a blue lit path. Frames six to seven then show Serena Williams walking down the blue lit path, no longer exhibiting migraine ...
Inquirer on MSN11h
New migraine drugs no better than cheap painkillers – big study
New, more expensive migraine drugs are no more effective against the throbbing headaches than traditional painkillers, and ...
2 Unstoppable S&P 500 Dividend Stocks to Buy Before They Beat the Market Again
Instead of four equal quarterly distributions, AstraZeneca insists on two payments per year, with a greater portion announced ...
FiercePharma9d
AbbVie's Ubrelvy to be top migraine seller in 2033
AbbVie’s migraine drug Ubrelvy (ubrogepant) is slated to be the top-selling drug in the migraine space in 2033 across the ...
Medpage Today on MSN21h
Older Migraine Drugs More Effective Than Newer Ones, Analysis Suggests
Three newer migraine drugs were included in the analysis: lasmiditan (Reyvow), rimegepant (Nurtec), and ubrogepant (Ubrelvy).